ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Personal Finance
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Web Stories
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Samco Acers
  • Samco Mission Ace The Index
  • Real Estate
    • Home Buyers
    • Builders
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » Markets News

Mukul Agrawal stock: This small-cap pharma company share price zooms 8% – Here’s why

The company’s gross profit was at Rs 218.9 crore, growing by over 17 per cent YoY with a gross margin at 50.5 per cent YoY, the pharma company said.  

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Mukul Agrawal stock: This small-cap pharma company share price zooms 8% – Here’s why
Renowned investor Mukul Agrawal has 50,00,000 equity shares or 1.22 per cent stakes in Marksans Pharma: PTI

Mukul Agrawal stock, Mukul Agrawal portfolio: Ace investor Mukul Agrawal owned small-cap company – Marksans Pharma share price jumped by 8 per cent to Rs 53.8 per share on the BSE intraday during Tuesday’s trading session. The surge in the stock was on the back of strong June quarter results for the financial year 2022-23 (Q1FY23). 

The company’s operating revenue was at Rs 433.8 crore, growing by over 24 per cent year-on-year (YoY) driven by strong volume growth in existing products and new launches in the US & UK, Marksans Pharma said in its results highlighted through exchange filing on Friday. 

While the company’s gross profit was at Rs 218.9 crore, growing by over 17 per cent YoY with a gross margin at 50.5 per cent YoY, the pharma company said.  

Similarly, EBITDA (earnings before interest, taxes, depreciation, and amortization) was at Rs 72.9 crore, declining by nearly 6 per cent with an EBITDA margin at around 17 per cent, on account of an increase in costs of material, freight costs and pricing pressure in the US, the filing said. 

The company has emerged as a prime manufacturer and marketer of private-label store brands of consumer healthcare products in the USA, UK, and Australia. This is driven by our commitment to investing in product innovation, newer capacities, and increasing penetration, the management said. 

Looking ahead, we see growing demand in our OTC segment across the regions, and we are well-positioned to take advantage of these opportunities, Mark Saldanha, MD of Marksans Pharma said. 

Renowned investor Mukul Agrawal has 50,00,000 equity shares or 1.22 per cent stakes in Marksans Pharma, according to the June 2022 shareholding pattern of the company available on the BSE. 

Mukul Agrawal publicly holds 53 stocks with a net worth of over Rs 2,414.8 crore as of August 16, 2022, as per the stock analysis website trendlyne.com. 

The stock on Tuesday closed between 6-7 per cent higher to Rs 52.95 and Rs 53.15 per share on the BSE and NSE as compared to a 0.64 and 0.72 per cent rise in the BSE Sensex and Nifty50 at the close. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Mukul AgrawalMarksans PharmaMukul Agrawal stockMukul Agrawal Portfolio
Written By: Vaibhav Gautam Bansode
Edited By: Abhinav Ranjan
Updated: Wed, Aug 17, 2022
11:25 am
Mumbai, ZeeBiz WebDesk
RELATED NEWS
What makes this Sunil Singhania, Mukul Agrawal portfolio stock attractive? Analyst sees Rs 250 upside What makes this Sunil Singhania, Mukul Agrawal portfolio stock attractive? Analyst sees Rs 250 upside
Marksans Pharma to double its manufacturing capacity – here’s why? Check analyst view, management’s commentary, share price history and more Marksans Pharma to double its manufacturing capacity – here’s why? Check analyst view, management’s commentary, share price history and more
Mukul Agrawal Portfolio: Ace investor adds three new stocks in his list during June 2022 quarter – know company details Mukul Agrawal Portfolio: Ace investor adds three new stocks in his list during June 2022 quarter – know company details
Mukul Agrawal Stocks: Small-cap pharma share zooms 18% - Know what’s fuelling the rally; Brokerage sees 86% upside Mukul Agrawal Stocks: Small-cap pharma share zooms 18% - Know what’s fuelling the rally; Brokerage sees 86% upside
This Mukul Agrawal textile stock may grow over 52% on strong export outlook and government initiatives This Mukul Agrawal textile stock may grow over 52% on strong export outlook and government initiatives

LATEST NEWS

Rate-sensitive stocks, oil-linked stocks, Mazagon Dock, Gati, and HeroMoto Corp, among top scrips to track today

Crude oil prices rise as Saudi Arabia output cuts outweigh weak demand signals

Cooperative banks will soon be able to do compromise settlements, write-offs on NPAs: RBI

L&T Finance dividend: Board announces Rs2/share payout

Should you buy, sell or hold Tata Motors, Maruti Suzuki, Paytm, HUL, Zomato, PB Fintech shares?

IOC, BPCL, HPCL: OMCs slip up to 4% in trade; here's why

Why Aadhaar-PAN linking is important and how to check status using income tax portal

Monsoon finally arrives in Kerala, a week later than usual, declares IMD

Covid-19 Cases in India Today: Active coronavirus cases dip to 2,687

Rate-sensitive stocks mixed bag: Nifty Bank and Financials rise after RBI keeps key rate unchanged

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. Indiadotcom Digital Private Limited. All Rights Reserved.
LIVE TV